Original Research
Published on 25 Feb 2020
Conducting a Virtual Clinical Trial in HER2-Negative Breast Cancer Using a Quantitative Systems Pharmacology Model With an Epigenetic Modulator and Immune Checkpoint Inhibitors
in Computational Genomics
- 12,480 views
- 49 citations








![Synthesis and Evaluation of a New Type of Small Molecule <mark class="highlighted">Epigenetic Modulator</mark> Containing Imidazo[1,2-b][1,2,4]triazole Motif](https://www.frontiersin.org/files/myhome article library/423501/423501_Thumb_400.jpg)